These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12113885)

  • 1. Regulation of Fas ligand expression by estrogen in normal ovary.
    Sapi E; Brown WD; Aschkenazi S; Lim C; Munoz A; Kacinski BM; Rutherford T; Mor G
    J Soc Gynecol Investig; 2002; 9(4):243-50. PubMed ID: 12113885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of fas ligand expression in breast cancer cells by estrogen: functional differences between estradiol and tamoxifen.
    Mor G; Kohen F; Garcia-Velasco J; Nilsen J; Brown W; Song J; Naftolin F
    J Steroid Biochem Mol Biol; 2000; 73(5):185-94. PubMed ID: 11070347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Fas ligand expression by estradiol and progesterone in human endometrium.
    Selam B; Kayisli UA; Mulayim N; Arici A
    Biol Reprod; 2001 Oct; 65(4):979-85. PubMed ID: 11566716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
    Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
    J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor-beta mRNA expression in rat ovary: down-regulation by gonadotropins.
    Byers M; Kuiper GG; Gustafsson JA; Park-Sarge OK
    Mol Endocrinol; 1997 Feb; 11(2):172-82. PubMed ID: 9013764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrous cycle dependent changes in expression and distribution of Fas, Fas ligand, Bcl-2, Bax, and pro- and active caspase-3 in the rat ovary.
    Slot KA; Voorendt M; de Boer-Brouwer M; van Vugt HH; Teerds KJ
    J Endocrinol; 2006 Feb; 188(2):179-92. PubMed ID: 16461545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the Fas/Fas ligand system in estrogen-induced thymic alteration.
    Mor G; Muñoz A; Redlinger R; Silva I; Song J; Lim C; Kohen F
    Am J Reprod Immunol; 2001 Oct; 46(4):298-307. PubMed ID: 11642679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of rats with 17beta-estradiol or relaxin rapidly inhibits uterine estrogen receptor beta1 and beta2 messenger ribonucleic acid levels.
    Pillai SB; Jones JM; Koos RD
    Biol Reprod; 2002 Dec; 67(6):1919-26. PubMed ID: 12444070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of Fas and Fas ligand gene expression in human ovarian, cervical and endometrial carcinomas using real-time quantitative RT-PCR.
    Das H; Koizumi T; Sugimoto T; Chakraborty S; Ichimura T; Hasegawa K; Nishimura R
    Br J Cancer; 2000 May; 82(10):1682-8. PubMed ID: 10817504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour Fas ligand:Fas ratio greater than 1 is an independent marker of relative resistance to tamoxifen therapy in hormone receptor positive breast cancer.
    Reimer T; Koczan D; Müller H; Friese K; Thiesen HJ; Gerber B
    Breast Cancer Res; 2002; 4(5):R9. PubMed ID: 12223126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymic atrophy via estrogen-induced apoptosis is related to Fas/FasL pathway.
    Yao G; Hou Y
    Int Immunopharmacol; 2004 Feb; 4(2):213-21. PubMed ID: 14996413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis of bovine ovarian surface epithelial cells by Fas antigen/Fas ligand signaling.
    Margalit KA; Cowan RG; Harman RM; Quirk SM
    Reproduction; 2005 Nov; 130(5):751-8. PubMed ID: 16264104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrous cycle-regulated expression of CYP1B1 mRNA in the rat ovary.
    Dasmahapatra AK; Trewin AL; Hutz RJ
    Comp Biochem Physiol B Biochem Mol Biol; 2002 Sep; 133(1):127-34. PubMed ID: 12223220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen and progesterone receptor subtype expression in normal and malignant ovarian epithelial cell cultures.
    Li AJ; Baldwin RL; Karlan BY
    Am J Obstet Gynecol; 2003 Jul; 189(1):22-7. PubMed ID: 12861133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of survivin in ovarian epithelial carcinoma and its correlation with expression of Fas and FasL].
    Ma XY; He FX; Wu SF; Lu YP; Ma D
    Ai Zheng; 2004 Feb; 23(2):173-6. PubMed ID: 14960238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ovarian hormone treatment on the gene expression of muscarinic acetylcholine receptors in the ovariectomized rat myometrium.
    Yasuda K; Sumi G; Kanamori C; Nakajima T; Tsuzuki T; Cho H; Nishigaki A; Okada H; Kanzaki H
    J Steroid Biochem Mol Biol; 2014 Sep; 143():81-9. PubMed ID: 24583025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrous cycle-dependent changes in the expression of aromatic hydrocarbon receptor (AHR) and AHR-nuclear translocator (ARNT) mRNAs in the rat ovary and liver.
    Chaffin CL; Trewin AL; Hutz RJ
    Chem Biol Interact; 2000 Feb; 124(3):205-16. PubMed ID: 10728779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17beta-estradiol.
    Song RX; Mor G; Naftolin F; McPherson RA; Song J; Zhang Z; Yue W; Wang J; Santen RJ
    J Natl Cancer Inst; 2001 Nov; 93(22):1714-23. PubMed ID: 11717332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Fas (CD95) and FasL (CD95L) in human airway epithelium.
    Hamann KJ; Dorscheid DR; Ko FD; Conforti AE; Sperling AI; Rabe KF; White SR
    Am J Respir Cell Mol Biol; 1998 Oct; 19(4):537-42. PubMed ID: 9761749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogens up-regulate the Fas/FasL apoptotic pathway in lactotropes.
    Jaita G; Candolfi M; Zaldivar V; Zárate S; Ferrari L; Pisera D; Castro MG; Seilicovich A
    Endocrinology; 2005 Nov; 146(11):4737-44. PubMed ID: 16099864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.